Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Rafael Amado files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ying Du - $8.58M of ZLAB open-market activity in the last 12 months
- Frazor Titus Edmondson III - $1.01M of ZLAB open-market activity in the last 12 months
- Joshua L. Smiley - $583K of ZLAB open-market activity in the last 12 months
- William Lis - $340K of ZLAB open-market activity in the last 12 months
- Yajing Chen - $239K of ZLAB open-market activity in the last 12 months
- Richard Gaynor - $66K of ZLAB open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Rafael Amado?
Rafael Amado is a corporate insider, tracked as President, Head of Global Oncology Research and Development of Zai Lab Ltd (ZLAB). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Rafael Amado last file a Form 4?
The most recent primary Form 4 on record is dated 8 April 2026, one of 6 filings going back to 2025.
Has Rafael Amado been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($780K) across all tracked filings.
Where can I see all of Rafael Amado's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Rafael Amado and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
